CM to inaugurate pharma company's city facility
Hyderabad, June 22 (INN): A delegation of United States Pharmacopeia (USP) called on the Chief Minister N Kiran Kumar Reddy and requested him to inaugurate their Hyderabad facility in September, 2011.
The United States Pharmacopeia (USP), an official public standards-setting authority for all prescription and over-the-counter medicines and other healthcare products, is setting up a new facility at the Genome Valley (ICICI Knowledge Park) on the outskirts of Hyderabad with an investment of $15 million (approximately Rs 68 crore). USP Vice President KV Surendranath led the delegation.
"The new 1,10,000-sft building that USP constructing on 4.5- acre land will be the 'second home'. The building is nearing completion. The facility will be the largest site for USP outside the US,' he told media persons after meeting the Chief Minister.
The facility will house analytical research and development, micro-biology, micro-analytical and organic synthetic chemistry labs, besides boosting facilities to conduct training programmes.
The organisation has been operating from a 10,000-sft leased space in Hyderabad since the last five years, Dr Surendranath said, adding that the objective behind expanding its India operations is that Indian offered a lot of opportunities for USP in many ways. 'The company started as a collaborative testing laboratory in Hyderabad,' he said.
Roughly 35 per cent of the drugs that are imported into the US come from India. USP's main customers (users) for its reference standards and USP books are all in India, accounting for 10-12 per cent of the organisation's global customers, Dr Surendranath said.
There was a natural synergy between USP and the India pharmaceutical industry in the development and establishment of public standards of the latter's drugs, USP was expanding its certification activities in the country, not just for India but also involving several other countries in the world. "Hyderabad will be their central location for providing certification services".
Hyderabad, June 22 (INN): A delegation of United States Pharmacopeia (USP) called on the Chief Minister N Kiran Kumar Reddy and requested him to inaugurate their Hyderabad facility in September, 2011.
The United States Pharmacopeia (USP), an official public standards-setting authority for all prescription and over-the-counter medicines and other healthcare products, is setting up a new facility at the Genome Valley (ICICI Knowledge Park) on the outskirts of Hyderabad with an investment of $15 million (approximately Rs 68 crore). USP Vice President KV Surendranath led the delegation.
"The new 1,10,000-sft building that USP constructing on 4.5- acre land will be the 'second home'. The building is nearing completion. The facility will be the largest site for USP outside the US,' he told media persons after meeting the Chief Minister.
The facility will house analytical research and development, micro-biology, micro-analytical and organic synthetic chemistry labs, besides boosting facilities to conduct training programmes.
The organisation has been operating from a 10,000-sft leased space in Hyderabad since the last five years, Dr Surendranath said, adding that the objective behind expanding its India operations is that Indian offered a lot of opportunities for USP in many ways. 'The company started as a collaborative testing laboratory in Hyderabad,' he said.
Roughly 35 per cent of the drugs that are imported into the US come from India. USP's main customers (users) for its reference standards and USP books are all in India, accounting for 10-12 per cent of the organisation's global customers, Dr Surendranath said.
There was a natural synergy between USP and the India pharmaceutical industry in the development and establishment of public standards of the latter's drugs, USP was expanding its certification activities in the country, not just for India but also involving several other countries in the world. "Hyderabad will be their central location for providing certification services".
News Posted: 22 June, 2011
|
